Search

Advanced sensation and actuation abilities of various living organisms in nature have inspired researchers to design bioinspired self‐sensing soft actuators. However, the majority of conventional soft actuators primarily possess actuation capabilities while lacking a real‐time sensing signal feedback. Here, a promising strategy is reported to develop highly stretchable and conductive hydrogels for bioinspired self‐sensing soft actuators, which integrate actuation and strain‐sensing functions into a single materials system. The conductive hydrogels are designed and fabricated by in situ copolymerization of amino‐functionalized MXene‐encapsulated liquid metal nanodroplets (LM@A‐MXene) and poly(N‐isopropylacrylamide) hydrogels with controllable activated nanogels as nano‐cross‐linkers. The resulting hydrogel presents a compacted conducting network and highly porous microstructure, giving rise to robust integration of high conductivity, excellent strain sensitivity, broad stretchability, high stability, and fast response speed. Interestingly, the gradient network structure, formed by self‐precipitation of LM@A‐MXene, endows the hydrogel with shape‐programmable actuation, light‐driven remote control, and self‐sensing function. As a proof‐of‐concept application, the soft gripper based on the self‐sensing hydrogel actuators is developed, which can not only grasp, lift, and release objects, but also perceive every movement state by monitoring resistance changes. The proposed self‐sensing soft actuator can offer new insights for developing smart soft robotics and other artificial intelligent devices. [ABSTRACT FROM AUTHOR]

This paper focuses on the facial micro-expression (FME) generation task, which has potential application in enlarging digital FME datasets, thereby alleviating the lack of training data with labels in existing micro-expression datasets. Despite obvious progress in the image animation task, FME generation remains challenging because existing image animation methods can hardly encode subtle and short-term facial motion information. To this end, we present a facial-prior-guided FME generation framework that takes advantage of facial priors for facial motion generation. Specifically, we first estimate the geometric locations of action units (AUs) with detected facial landmarks. We further calculate an adaptive weighted prior (AWP) map, which alleviates the estimation error of AUs while efficiently capturing subtle facial motion patterns. To achieve smooth and realistic synthesis results, we use our proposed facial prior module to guide motion representation and generation modules in mainstream image animation frameworks. Extensive experiments on three benchmark datasets consistently show that our proposed facial prior module can be adopted in image animation frameworks and significantly improve their performance on micro-expression generation. Moreover, we use the generation technique to enlarge existing datasets, thereby improving the performance of general action recognition backbones on the FME recognition task. Our code is available at https://github.com/sysu19351158/FPB-FOMM. [ABSTRACT FROM AUTHOR]

Air-permeable building envelopes (APBEs) utilize the infiltrated or exfiltrated airflow within porous materials to directly change their temperature distribution to reduce heat loss/gain. APBEs effectively integrate building ventilation and heat recovery to achieve excellent thermal insulation while improving indoor air quality. This paper presents a comprehensive review of the fundamentals and classifications, historical evolution over time, opportunities and benefits, and future views on APBEs. It can be treated as a responsive building envelope that enables building envelopes to dynamically change the U-values by varying the infiltrated or exfiltrated airflow rate within a porous material. Previous studies have indicated that the U-value of 0.1 W/(m2·K) can be realized by employing APBEs. Moreover, some research demonstrates that APBEs could act as high-performance air filters that reduce over 90% of particulate matter within fresh, ventilated air. Some factors, such as airflow rate, thickness, and thermal conductivity of porous materials, have a significant influence on the effectiveness of APBEs. For practical applications, integrating the APBE with passive building ventilation can help reduce the initial cost and facilitate decarbonization in buildings. Moreover, advanced control strategies could collaboratively optimize the operation of ABPEs and build energy systems to maximize their energy-saving potential. [ABSTRACT FROM AUTHOR]

Background: Zorifertinib (AZD3759), an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) with high blood-brain barrier penetration capability, demonstrated promising intracranial and systemic antitumor activity in phase 1 and 2 studies in central nervous system (CNS)-metastatic patients., Methods: In this phase 3 EVEREST trial (ClinicalTrials.gov: NCT03653546), patients with EGFR-sensitizing mutations, advanced treatment-naive non-small cell lung cancer (NSCLC), and non-irradiated symptomatic or asymptomatic CNS metastases were randomized (1:1) to zorifertinib or first-generation EGFR-TKI (gefitinib or erlotinib; control). The primary endpoint was blinded independent central review (BICR)-assessed progression-free survival (PFS) per RECIST1.1., Findings: Overall, 439 patients were randomized (zorifertinib n = 220; control n = 219). Most patients had the EGFR L858R mutation (55%) or >3 CNS lesions (54%). Median PFS was significantly longer with zorifertinib versus control (9.6 versus 6.9 months; hazard ratio [HR], 0.719; 95% confidence interval [CI], 0.580-0.893; p = 0.0024). Zorifertinib significantly prolonged intracranial PFS versus control (BICR per modified RECIST1.1: HR, 0.467; 95% CI, 0.352-0.619; investigator per RANO-BM: HR, 0.627; 95% CI, 0.466-0.844). Overall survival (OS) was immature; the estimated median OS was 37.3 months with zorifertinib and 31.8 months with control (HR, 0.833; 95% CI, 0.524-1.283) in patients subsequently treated with third-generation EGFR-TKIs. Safety profiles were consistent with previously reported data for zorifertinib., Conclusions: Zorifertinib significantly improved systemic and intracranial PFS versus first-generation EGFR-TKIs; adverse events were manageable. Sequential use of zorifertinib and third-generation EGFR-TKIs showed the potential to prolong patients' survival. The results favor zorifertinib as a novel, well-validated first-line option for CNS-metastatic patients with EGFR-mutant NSCLC., Funding: This work was funded by Alpha Biopharma (Jiangsu) Co., Ltd., China., Competing Interests: Declaration of interests Q.Z. declares lecture and presentation fees from AstraZeneca, Boehringer Ingelheim, BMS, Eli Lilly, MSD, Pfizer, Roche, and Sanofi. S.L. declares grants or contracts from AstraZeneca, Hutchison, BMS, Hengrui, BeiGene, Roche, and Hansoh; consulting fees from AstraZeneca, Pfizer, Boehringer Ingelheim, Hutchison Medipharma, Simcere, Zai Lab, GenomiCare, Yuhan, prlME Oncology, Menarini, InventisBio, and Roche; lecture and presentation fees from AstraZeneca, Roche, Hansoh, and Hengrui Therapeutics; participation on a data safety monitoring board or advisory board for Roche, Regeneron, AstraZeneca, and Xcovery Holdings; and a leadership or fiduciary role in the Chinese Lung Cancer Associate and CSCO. Z. Wang is an employee of Alpha Biopharma (Jiangsu) and declares no stock ownership in the company. M.-J.A. declares consulting fees from AstraZeneca, Amgen, Merck, Takeda, BMS, ONO, Roche, Daiichi-Sankyo, Janssen, Alpha Pharmaceuticals, Yuhan, Arcus Biosciences, Eutilex, and VORONOI and lecture and presentation fees from AstraZeneca, Amgen, Merck, Takeda, BMS, ONO, Roche, Daiichi-Sankyo, Janssen, and Yuhan. Y.-L.W. declares consulting services for AstraZeneca, Boehringer Ingelheim, Novartis, and Takeda; lecture and presentation fees from AstraZeneca, BeiGene, Boehringer Ingelheim, BMS, Eli Lilly, MSD, Pfizer, Roche, and Sanofi; and grants or contracts from AstraZeneca, Boehringer Ingelheim, BMS, Hengrui, and Roche., (Copyright © 2024 Elsevier Inc. All rights reserved.)

Colorectal cancer (CRC) is among the most prevalent malignant tumors, known for its high heterogeneity. Although many treatments and medications are available, the long-term survival rate of CRC patients is far from satisfactory. Pyroptosis is closely related to tumor progression. This study aimed to identify pyroptosis-related genes (PRGs) and candidate biomarkers to predict the prognosis of CRC patients. Used bioinformatics, we identified PRGs and subsequently screened 288 co-expression genes between pyroptosis-related modules and differentially expressed genes in CRC. Among these hub genes, we selected the top 24 for further analysis and found that Radical S-Adenosyl Methionine Domain Containing 2 (RSAD2) was a novel biomarker associated with the progression of CRC. We developed a risk model for RSAD2, which proved to be an independent prognostic indicator. The receiver operator characteristic analysis showed that the model had an acceptable prognostic value for patients with CRC. In addition, RSAD2 also affects the tumor immune microenvironment and prognosis of CRC. We further validated RSAD2 expression in CRC patients using RT-qPCR and the role of RSAD2 in pyroptosis. Taken together, this study comprehensively assessed the expression and prognostic value of RSAD2 in patients with CRC. These findings may offer a new direction for early CRC screening and development of future immunotherapy strategies., Competing Interests: None., (AJCR Copyright © 2024.)

Nonradicals are effective in selectively degrading electron-rich organic contaminants, which unfortunately suffer from unsatisfactory yield and uncontrollable composition due to the competitive generation of radicals. Herein, we precisely construct a local microenvironment of the carbon nitride-supported high-loading (~9 wt.%) Fe single-atom catalyst (Fe SAC) with sulfur via a facile supermolecular self-assembly strategy. Short-distance S coordination boosts the peroxymonosulfate (PMS) activation and selectively generates high-valent iron-oxo species (Fe IV =O) along with singlet oxygen ( 1 O 2 ), significantly increasing the 1 O 2 yield, PMS utilization, and p -chlorophenol reactivity by 6.0, 3.0, and 8.4 times, respectively. The composition of nonradicals is controllable by simply changing the S content. In contrast, long-distance S coordination generates both radicals and nonradicals, and could not promote reactivity. Experimental and theoretical analyses suggest that the short-distance S upshifts the d -band center of the Fe atom, i.e., being close to the Fermi level, which changes the binding mode between the Fe atom and O site of PMS to selectively generate 1 O 2 and Fe IV =O with a high yield. The short-distance S-coordinated Fe SAC exhibits excellent application potential in various water matrices. These findings can guide the rational design of robust SACs toward a selective and controllable generation of nonradicals with high yield and PMS utilization., Competing Interests: Competing interests statement:The authors declare no competing interest.